
Chicago-based Regenerative Medical Solutions, Inc. pioneers in biotechnology, harnessing human stem cells for regeneration.
Regenerative Medical Solutions, Inc., founded in 2012 and based in Chicago, aims to revolutionize biotechnology by leveraging the regenerative properties of human-induced pluripotent stem cells (iPSCs). Originating from Dr. Jon Odorico’s research at the University of Wisconsin, the company focuses on developing scalable, ethical, and cutting-edge therapeutic solutions for diabetes. Their core mission is to create life-changing treatments that harness the power of stem cells to regenerate damaged tissues and organs.
Notable figures affiliated with Regenerative Medical Solutions include Dr. Jon Odorico, whose pioneering research laid the foundation for the company's innovations. The startup has garnered attention from key investors in the biotech sector, contributing to its rapid growth and development. Among its achievements, the company has secured multiple patents and licenses, published significant scientific research, and made strides in creating scalable products for diabetes treatment. Their work has had a profound impact on advancing regenerative medicine and offering new hope for patients with chronic conditions.
Companies similar to Regenerative Medical Solutions include Regen BioPharma, Regenemed, ViaCyte and Stemedica Cell Technologies.
Regenerative Medical Solutions was founded in 2010.
Regenerative Medical Solutions' headquarters is located in Chicago, IL, US.
Regenerative Medical Solutions' most recent funding round was for $5M (USD) in August 2023.
As of Aug 28, 2023, Regenerative Medical Solutions has raised a total of $6.5M (USD).
Regenerative Medical Solutions has 15 employees as of Feb 5, 2024.
ViaCyte